⌘K

Login Start Free

Home/Filings/4/0001645113-21-000095

4//SEC Filing

Benaim Ely 4

Accession 0001645113-21-000095

CIK 0001645113other

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 4:59 PM ET

Size

4.7 KB

Accession

0001645113-21-000095

Insider Transaction Report

Form 4

Period: 2021-08-03

NovoCure LtdNVCR

Chief Medical Officer

Transactions

Sale
Ordinary Shares
2021-08-03$150.11/sh−464$69,651→ 28,144 total

Footnotes (1)

[F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.

Documents

1 file

4
wf-form4_162811071615273.xmlPrimary
FORM 4

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1

filerCIK 0001632237

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 4:59 PM ET
Size: 4.7 KB

View on SEC.gov